The slower development of Eμ-myc lymphomas deficient in IL-6 may rely on activation of non-STAT pathways such as MAPK/ERK and PI3K/AKT, or STAT pathways activated by other cytokines. This evidence concerns the gene AKT1 and lymphoma.